If the plan was to go at this alone, what is the importance of achieving Direct milestones right now? would you agree that this activity points to buyout?
Things learned in Direct Phase 1 play right into how to improve outcomes in pretty much all cancer types and related back to L and improvements that I believe were made outside of the trial. I believe that Kat’s dramatic cure and Mr. Powers recovery were proof that what they learned was THAT important. Worth getting everything in patented form and the first move was in 2014 right about the time Mr. Neil Woodford first invested. Coincidence? I think not. Lot’s of very interesting maneuvering in 2014-2015. Best wishes.
Market Data 
Markets 
AI
